<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03309800</url>
  </required_header>
  <id_info>
    <org_study_id>HL_HL301_202</org_study_id>
    <nct_id>NCT03309800</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients</brief_title>
  <official_title>A Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel, Phase II Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hanlim Pharm. Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hanlim Pharm. Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel, Phase II Clinical
      Trial to Evaluate the Efficacy and Safety of HL301 versus Placebo in acute bronchitis
      patients.

      Endpoint: BSS, The improvement and improvement rate of the tester for the treatment response,
      The satisfaction of the subject, Total usage of Acetaminophen
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 29, 2017</start_date>
  <completion_date type="Actual">August 28, 2017</completion_date>
  <primary_completion_date type="Actual">August 17, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bronchitis Severity Total Score(BSS) Change</measure>
    <time_frame>Visit 1 (-3 day), Visit 2 (0 day), Visit 3 (7 day)</time_frame>
    <description>Evaluation period: Visit 1 (-3 day), Visit 2 (0 day), Visit 3 (7 day)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The improvement and improvement rate of the tester for the treatment response (Chi-square test or Fisher's Exact test)</measure>
    <time_frame>Visit 3 (7 day)</time_frame>
    <description>Evaluation period: Visit 3 (7 day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The satisfaction of the subject (Questionnaire)</measure>
    <time_frame>Visit 3 (7 day)</time_frame>
    <description>Evaluation period: Visit 3 (7 day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total usage of Acetaminophen</measure>
    <time_frame>Visit 3 (7 day)</time_frame>
    <description>Evaluation period: Visit 3 (7 day)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">168</enrollment>
  <condition>Acute Bronchitis</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HL301: 2Tab/day: 1 Tablet at once, 2 times a day, 7 days of treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>HL301(Placebo): 2Tab/day: 1 Tablet at once, 2 times a day, 7 days of treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HL301</intervention_name>
    <description>HL301: 2Tab/day: 1 Tablet at once, 2 times a day, 7 days of treatment</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HL301(Placebo)</intervention_name>
    <description>HL301(Placebo): 2Tab/day: 1 Tablet at once, 2 times a day, 7 days of treatment</description>
    <arm_group_label>Placebo comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Both gender, 19 years ≤ age ≤ 80 years

          2. (Bronchitis Severity Score)* ≥ 5point at Visit 2 (Randomized Visit)

          3. Acute bronchitis within 48hr based on Visit 2 (Randomized Visit)

          4. Those who can comply with the requirements of clinical trials

          5. Written consent voluntarily to participate in this clinical trial

        Exclusion Criteria:

          1. Patients with respiratory and systemic infections requiring systemic antibiotic
             therapy

          2. Patients with bleeding tendency

          3. Patients who investigators determines to severe respiratory disease that would
             interfere with study assessment

          4. Patients who were treated with oral systemic adrenocortical hormone or
             immunosuppressive drug within 4 weeks prior to Visit 2

          5. Patients who were treated with oral antihistamines, ACE suppressive. or
             systemic/inhalative glucocorticosteroid within 2 weeks prior to Visit 2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kyung Hee University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Dongdaemun-gu</state>
        <zip>130-872</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2017</study_first_submitted>
  <study_first_submitted_qc>October 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2017</study_first_posted>
  <last_update_submitted>October 10, 2017</last_update_submitted>
  <last_update_submitted_qc>October 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Bronchitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Acute Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

